Skip to main content

The scientific journal PLOS ONE published an article on the first-in-human trial studying safety and effectiveness of an attenuated HIV-1 adenovirus vector vaccine by the group of Dr. Dan Barouch. Batavia Biosciences participated in these studies by developing the manufacturing process for the attenuated vaccine and the delivery of the vaccine to be tested in humans.

Read the full article.